Active Ingredient: CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
Proprietary Name: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 5MG;2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A211476
Product Number: 001
Approval Date: Nov 2, 2021
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
